Synopsis
In 2011, two major things happened for Sanofi that put them in a unique position. First they acquired Genzyme, the world's third-largest biotechnology company in the world; and second, they had two MS products to launch worldwide – in the same time and place. This situation was a first in the world of MS, and our client consequently had to do more in less time.
The traditional relationship between a healthcare market research agency and a client is generally ad hoc (project-by-project), but in this situation there was no time to repeat multiple learnings with multiple agencies between different...